Yinghong Wang

51PUBLICATIONS
145CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Aug 10, 2026
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Upper Gastrointestinal Adverse Events in Patients Receiving Platinum Analog-Based Chemotherapy.

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Feb 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapy.

Andrew G Kuang, Malek Shatila, Jay S Shah

|Dec 11, 2025
Beyond Proton Pump Inhibitors: Evaluating Treatment Strategies for Immune-Mediated Gastroenteritis from Cancer Immunotherapy.

Carolina Colli Cruz, Maria Julia Moura Nascimento Santos, Sharada Wali

|Dec 10, 2025
Patterns of immune-related adverse events and treatment responses in adolescents and young adults with melanoma during initial and rechallenge immune checkpoint inhibitor therapy.

Jiasen He, Ida N John, Mianen Sun

|Aug 11, 2025
Gastrointestinal Infection Before Immune Checkpoint Inhibition Hinders Treatment Efficacy and Increases the Risk of Colitis.

Malek Shatila, Kian Abdul-Baki, Andres Urias Rivera

Pageof 9

Frequent Collaborators

6 joint publications

Malek Shatila

4 joint publications

Anusha Shirwaikar Thomas

4 joint publications

Marc S Ernstoff

3 joint publications

Hamzah Abu-Sbeih